Senate panel approves streamlined licensure rules across multiple health professions; pharmacy compounding labeling language removed after stakeholder concerns

The Senate Health and Welfare Committee on the morning of the meeting reviewed and approved a series of rule dockets that rewrite and consolidate professional-licensure rules across several health boards, while taking specific changes for the Idaho State Board of Pharmacy after stakeholder concerns about compounded drug labeling.

Idaho State Board of Pharmacy: temporary rule expires; pending rule approved with labeling subparts struck Nikki Chopsky, bureau chief for health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy, told the committee the board conducted a comprehensive zero-based review that produced more than 35 changes to the pharmacy rules. The package reorganized definitions, moved duplicative language into statute, changed inventory cycles, updated reporting deadlines and moved fee tables into a single rule, among other changes. The board recommended the committee take no action on the earlier temporary docket (24-3601-2401) so it may expire; the committee voted to take no action on that temporary docket.

Compounding and labeling drew the most debate. Chopsky described stakeholder outreach and said the board retained a labeling provision that mirrors federal requirements for distribution of compounded products; she explained there are “legal pathways in Idaho for compounded products to be labeled and used,” and that some stakeholders raised concerns after recent federal draft guidance.

Senator Lenny moved to approve the pending pharmacy docket…